Atlas Trials

Cinnagen

21 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Cinnagen

RecordFirmDate
Spartina® (Tirzepatide) Effectiveness and Safety Evaluation (NCT07262762)Cinnagen2025-11-11
Immunogenicity and Safety of the SpikoGen COVID-19 Vaccine in Children Aged 5 to <12 Years and 12 to <18 Years Compared With Adults Aged 18 to 40 Years (NCT05231590)Cinnagen2022-02-23
Immunogenicity and Safety of a Booster Dose of the SpikoGen Vaccine in Kidney Transplant Recipients After Two Doses of Sinopharm Vaccine (NCT05285384)Cinnagen2022-02-04
Immunogenicity and Safety of a Booster Dose of the SpikoGen COVID-19 Vaccine (NCT05175625)Cinnagen2021-12-15
Phase III Clinical Trial of CinnaGen COVID-19 Vaccine (SpikoGen) (NCT05005559)Cinnagen2021-08-07
Efficacy and Safety of Zerafil® (Omalizumab) in Participants With Uncontrolled Moderate to Severe Allergic Asthma (NCT05813470)Cinnagen2021-01-18
Efficacy and Safety of Aflibercept in Patients With Neovascular Age-related Macular Degeneration (NCT05587062)Cinnagen2019-10-01
Efficacy and Safety of Xacrel® (Ocrelizumab) in Participants With Relapsing Remitting Multiple Sclerosis (NCT04966338)Cinnagen2019-08-19
Comparing Efficacy and Safety of CinnaGen-liraglutide Versus Victoza® in Patients With Type II Diabetes (NCT03421119)Cinnagen2019-06-20
Comparing Efficacy and Safety Between Pertuzumab® and Perjeta® in Neoadjuvant Treatment of HER2+ Breast Cancer (NCT04957212)Cinnagen2018-08-11
Comparing Efficacy and Safety of Cetuximab (CinnaGen) Versus Erbitux® (Merck) in Metastatic Colorectal Cancer (NCT03391934)Cinnagen2018-01-20
Efficacy and Safety of Peginterferon Beta-1a (CinnaGen) in Participants With Relapsing Remitting Multiple Sclerosis (NCT05242133)Cinnagen2017-12-20

Track Cinnagen automatically

Every clearance here is in the API, with alerts when new ones post.